Cite
MLA Citation
Michael Herold et al.. “Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial.” HemaSphere, vol. 6, no. 3, 2022, pp. e699–. http://access.bl.uk/ark:/81055/vdc_100151260357.0x000003